Jul 16, 2026 08:30AM
Jul 16, 2026 08:30AM
Jun 11, 2026 03:03PM
May 7, 2026 07:30AM
Apr 2, 2026 08:05AM
Apr 2, 2026 08:05AM
Feb 24, 2026 07:30AM Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion
Feb 17, 2026 08:05AM
Jan 12, 2026 08:07AM
Jan 12, 2026 08:05AM
Nov 24, 2025 08:06AM
Nov 24, 2025 08:05AM
Nov 19, 2025 08:05AM
Nov 4, 2025 07:30AM Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M
Oct 23, 2025 08:05AM
Oct 23, 2025 08:05AM
Aug 5, 2025 07:30AM
Aug 5, 2025 07:30AM
Jun 11, 2025 08:06AM
Jun 11, 2025 08:05AM
Jun 5, 2025 08:06AM Harmony Biosciences (HRMY) Announces Favorable Settlement in ANDA Litigation
Jun 5, 2025 08:05AM
May 6, 2025 07:30AM
Apr 8, 2025 08:05AM
Apr 8, 2025 08:05AM
Mar 24, 2025 08:05AM
Mar 24, 2025 08:05AM
Feb 25, 2025 07:30AM Harmony Biosciences Reports Strong 2024 Financial Results and Reiterates 2025 Net Revenue Guidance; Highlights 2025 Catalysts in Sleep/Wake and Fragile X Syndrome Development Programs
Feb 19, 2025 08:05AM
Feb 19, 2025 08:05AM
Jan 13, 2025 08:17AM
Jan 13, 2025 08:05AM
Oct 29, 2024 07:30AM
Aug 6, 2024 07:30AM
Aug 6, 2024 07:30AM Harmony Biosciences Reports Strong Second Quarter 2024 Financial Results and Advances Pitolisant High-Dose Program Toward Expected PDUFA Date in 2028
Jun 25, 2024 08:09AM
Jun 25, 2024 08:05AM
Jun 24, 2024 07:03AM
Jun 24, 2024 07:00AM
Jun 5, 2024 08:06AM
Jun 5, 2024 08:05AM
May 1, 2024 07:15AM Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $52 at Needham
Apr 30, 2024 12:17PM
Apr 30, 2024 07:08AM
Apr 30, 2024 07:05AM
Apr 30, 2024 07:00AM
Apr 11, 2024 08:05AM
Apr 3, 2024 08:05AM
Apr 3, 2024 08:05AM HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME
Feb 22, 2024 07:30AM

1,168,813 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All